GO:0062112 fatty acid primary amide biosynthetic process: Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0062112 describes the biological process that produces fatty acid primary amides, a class of lipid signaling molecules including oleamide and anandamide-like compounds.
• The process is best studied through the biosynthesis of oleamide, which proceeds from oleic acid via an acyl-CoA intermediate and a fatty acid amide synthase activity in the endoplasmic reticulum.
• Fatty acid primary amides such as oleamide modulate sleep, thermoregulation, and nociception, and their levels are controlled by synthesis and by hydrolysis via fatty acid amide hydrolase (FAAH).
• FAAH inhibition protects microglia from UVB-induced inflammatory activation, linking this biosynthetic pathway to skin barrier and neuroinflammation biology.
• Acetaminophen (paracetamol) is proposed to act partly through fatty acid amide signaling pathways, including the TRPV1 and cannabinoid systems, connecting this GO term to analgesic mechanisms.
• Hepatocyte Mas activation enhances lipophagy and fatty acid oxidation, showing that fatty acid handling pathways intersect with acetaminophen-induced hepatotoxicity and lipid signaling.
Description
GO:0062112, fatty acid primary amide biosynthetic process, is the biological process that generates fatty acid primary amides, a family of lipid-derived signaling molecules in which a fatty acid is linked to an amide nitrogen. These molecules include oleamide, a primary amide of oleic acid that was one of the first endogenous fatty acid amides characterized in mammalian tissue. The process is distinct from general fatty acid synthesis because it produces the amide headgroup rather than a free carboxylic acid or a glycerolipid. Understanding this pathway matters because fatty acid primary amides act as neuromodulators and immune regulators, and their steady-state levels depend on the balance between biosynthesis and hydrolysis by enzymes such as fatty acid amide hydrolase (FAAH). Researchers study GO:0062112 to define how lipid signals are made, how they are degraded, and how their dysregulation contributes to pain, sleep, inflammation, and drug responses. Because the pathway sits at the intersection of lipid metabolism and signaling, it is relevant to neuroscience, immunology, dermatology, and hepatology.
fatty acid primary amide biosynthetic process At A Glance
| GO ID | GO:0062112 |
|---|---|
| GO term | fatty acid primary amide biosynthetic process |
| Ontology | biological_process |
| Synonym | FAPA biosynthesis; FAPA biosynthetic process; fatty acid amide biosynthesis |
| Definition | The chemical reactions and pathways resulting in the formation of a fatty acid primary amide. |
| Major function | Production of fatty acid primary amides such as oleamide, which act as lipid signaling molecules. |
| Representative product | Oleamide, the primary amide of oleic acid. |
| Key degradative counterpart | Fatty acid amide hydrolase (FAAH), which hydrolyzes fatty acid amides and opposes this biosynthetic process. |
| Subcellular context | Endoplasmic reticulum membranes, where fatty acid amide biosynthesis is thought to occur. |
| Related disease areas | Pain and nociception, sleep regulation, neuroinflammation, skin barrier dysfunction, and drug-induced hepatotoxicity. |
What Is GO:0062112?
In plain terms, GO:0062112 describes the set of chemical reactions and pathways that build fatty acid primary amides, which are fatty acids whose carboxyl group has been converted into a primary amide. The QuickGO definition states that this process comprises the chemical reactions and pathways resulting in the formation of a fatty acid primary amide. It is a biological process, not a single enzyme or a single molecule, and it includes the activation of a fatty acid, the formation of an amide bond with ammonia or an amine donor, and the release of the primary amide product. Synonyms include FAPA biosynthesis, FAPA biosynthetic process, and fatty acid amide biosynthesis. The best-characterized example is the biosynthesis of oleamide from oleic acid, which requires an acyl-CoA intermediate and a fatty acid amide synthase activity.
Why Is fatty acid primary amide biosynthetic process Important in Cell Biology?
GO:0062112 is important because fatty acid primary amides are endogenous lipid signals that influence sleep, body temperature, pain perception, and inflammation, and their production is a regulated metabolic process rather than a passive chemical event. The pathway is also a point of pharmacological intersection: acetaminophen (paracetamol) is proposed to act in part through fatty acid amide signaling, including TRPV1 and cannabinoid-related mechanisms. In the skin, fatty acid amide hydrolase inhibition protects UVB-activated microglia, indicating that the balance of fatty acid amide synthesis and degradation shapes inflammatory responses in barrier tissues. In the liver, hepatocyte Mas activation enhances lipophagy and fatty acid oxidation and protects against acetaminophen-induced hepatotoxicity, showing that fatty acid handling pathways are central to drug-induced liver injury. Because the pathway is enzymatically controlled, it is a tractable target for genetic and pharmacological studies, and CRISPR-based models can help determine which enzymes are truly required for fatty acid primary amide production in specific cell types.
• Fatty acid primary amides such as oleamide are endogenous signaling lipids that modulate sleep and thermoregulation.
• The pathway produces ligands that interact with cannabinoid and TRPV1-related signaling systems, linking it to pain and analgesia.
• Fatty acid amide hydrolase (FAAH) degrades fatty acid amides and is a key counter-regulatory enzyme for this biosynthetic process.
• FAAH inhibition protects UVB-activated microglia, connecting the pathway to neuroinflammation and skin biology.
• Acetaminophen mechanisms of action have been proposed to involve fatty acid amide pathways, making this GO term relevant to analgesic pharmacology.
• Hepatocyte Mas activation enhances lipophagy and fatty acid oxidation and protects against acetaminophen-induced hepatotoxicity, linking lipid handling to liver injury.
• Stratum corneum lipid composition, including fatty acid derivatives, is critical for skin barrier function in health and atopic dermatitis.
• The pathway is a model for studying amide bond formation in lipid metabolism and for identifying fatty acid amide synthases.
• Genetic models of this pathway can clarify which enzymes are required for fatty acid primary amide production in vivo.
• The pathway intersects with endocannabinoid hydrolase biology, which is relevant to neurological and inflammatory disease.
What Happens During fatty acid primary amide biosynthetic process?
Fatty acid activation to an acyl-CoA intermediate
In simple terms: First, the fatty acid is switched on by attaching it to coenzyme A, making it reactive.
The biosynthesis of fatty acid primary amides begins with the activation of a fatty acid, typically through conversion to an acyl-CoA thioester. In the best-studied example, oleic acid is converted to oleoyl-CoA before the amide nitrogen is introduced. This activation step raises the chemical reactivity of the carboxyl carbon and is a common strategy in lipid metabolism. The acyl-CoA intermediate is the substrate for the subsequent amide-forming reaction, and its availability helps determine the rate of fatty acid primary amide production.
Amide bond formation by a fatty acid amide synthase activity
In simple terms: Next, an enzyme replaces the CoA group with ammonia or an amine, creating the primary amide.
The central step of GO:0062112 is the formation of the amide bond that defines a fatty acid primary amide. In oleamide biosynthesis, an acyl-CoA and an ammonia equivalent are combined by a fatty acid amide synthase activity to produce oleamide. This reaction converts the activated acyl group into a primary amide, releasing coenzyme A. The enzyme or enzymes responsible for this activity are the subject of ongoing research, and the reaction is thought to occur in membrane compartments such as the endoplasmic reticulum.
Product release and subcellular localization
In simple terms: The finished fatty acid amide is released and can move to act as a signal.
After the amide bond is formed, the fatty acid primary amide product is released from the enzyme and can diffuse or be transported to its sites of action. Oleamide is a lipophilic molecule that can associate with membranes and interact with protein targets. The biosynthetic process is closely tied to the endoplasmic reticulum, where lipid-modifying enzymes are concentrated. The localization of the synthesis machinery helps determine which fatty acid amides are produced and where they act.
Balance with hydrolysis by fatty acid amide hydrolase
In simple terms: The amount of fatty acid amide in a cell depends on both how much is made and how much is broken down.
Fatty acid primary amide levels are not determined by biosynthesis alone. Fatty acid amide hydrolase (FAAH) hydrolyzes fatty acid amides, including oleamide and endocannabinoid-related substrates, and therefore acts as a degradative counterpart to GO:0062112. The balance between synthesis and FAAH-mediated hydrolysis controls the steady-state concentration of these signaling lipids. Inhibiting FAAH can increase fatty acid amide levels and has been shown to protect UVB-activated microglia, demonstrating that the pathway's output is functionally important in inflammation.
Integration with broader lipid and energy metabolism
In simple terms: This pathway does not work alone; it is connected to how cells use and store fats.
Fatty acid primary amide biosynthesis is embedded in broader lipid and energy metabolism. Hepatocyte Mas activation enhances lipophagy and fatty acid oxidation, showing that fatty acid handling pathways are dynamically regulated and can protect against acetaminophen-induced hepatotoxicity. Acetaminophen itself has been proposed to act through fatty acid amide-related mechanisms, linking analgesic pharmacology to this biosynthetic process. In the skin, stratum corneum lipids, including fatty acid derivatives, are essential for barrier function, and their composition changes in atopic dermatitis. These connections indicate that GO:0062112 is part of a larger network of lipid signaling and metabolic regulation.
Key Genes Involved in GO:0062112 fatty acid primary amide biosynthetic process
The following genes and proteins are experimentally linked to fatty acid primary amide biosynthesis, its regulation, or its downstream signaling, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FAAH | Hydrolyzes fatty acid amides, opposing the biosynthetic process | Key degradative enzyme; target for increasing fatty acid amide signaling |
| Oleamide synthase (uncharacterized activity) | Catalyzes amide bond formation in oleamide biosynthesis | Central enzyme activity of GO:0062112; identity still being defined |
| Oleic acid / oleoyl-CoA pathway | Provides the fatty acid substrate for oleamide production | Substrate supply influences fatty acid primary amide levels |
| TRPV1 | Receptor targeted by fatty acid amide-related signaling | Links the pathway to pain and analgesic mechanisms |
| Cannabinoid receptors (CNR1/CNR2) | Mediate effects of endocannabinoid-related fatty acid amides | Connects the pathway to neuromodulation and inflammation |
| Mas receptor (MAS1) | Enhances lipophagy and fatty acid oxidation in hepatocytes | Protects against acetaminophen-induced hepatotoxicity |
| Acetaminophen-metabolizing enzymes (e.g., CYP2E1, UGT, SULT) | Determine acetaminophen metabolism and toxicity | Relevant to drug-induced liver injury and fatty acid amide interactions |
| Microglial inflammatory mediators (e.g., cytokines, COX-2) | Respond to fatty acid amide signaling after UVB exposure | Readouts for FAAH inhibition in neuroinflammation |
| Stratum corneum lipid enzymes (e.g., ceramide synthases, fatty acid elongases) | Maintain skin barrier lipid composition | Relevant to atopic dermatitis and barrier function |
| Endocannabinoid hydrolases (e.g., FAAH, MAGL) | Regulate endocannabinoid and fatty acid amide levels | Broader family of lipid signaling enzymes |
| Mitochondrial activity regulators | Tune nociceptor resilience to excitotoxicity | Links lipid signaling to neuronal survival |
| Neuroendocrine differentiation markers | Associated with acetate utilization and therapy resistance in prostate cancer | Connects lipid metabolism to cancer plasticity |
| Fatty acid oxidation enzymes (e.g., CPT1A, ACOX1) | Oxidize fatty acids for energy | Intersect with fatty acid amide precursor pools |
| Lipophagy machinery (e.g., LC3, ATG proteins) | Degrade lipid droplets and release fatty acids | Regulated by Mas activation in hepatocytes |
| Inflammatory signaling kinases (e.g., p38, NF-kB pathway components) | Transduce fatty acid amide signals in microglia | Potential readouts for FAAH inhibition studies |
| Sleep and thermoregulation neural circuits | Physiological outputs of oleamide signaling | Behavioral relevance of fatty acid primary amides |
How Is fatty acid primary amide biosynthetic process Regulated?
Fatty acid primary amide biosynthesis is regulated at multiple levels. Substrate availability, particularly the pool of fatty acids and acyl-CoA intermediates, influences how much primary amide can be produced. The degradative enzyme FAAH sets the steady-state level of fatty acid amides by hydrolyzing them, so changes in FAAH expression or activity effectively regulate the pathway's output. In hepatocytes, Mas receptor activation enhances lipophagy and fatty acid oxidation, which can alter fatty acid availability and protect against acetaminophen-induced hepatotoxicity. Acetaminophen itself has been proposed to modulate fatty acid amide-related signaling, adding a pharmacological layer of regulation. In the skin and nervous system, inflammatory stimuli such as UVB can activate microglia and shift the balance of fatty acid amide synthesis and degradation. Finally, mitochondrial activity tunes nociceptor resilience to excitotoxicity, suggesting that cellular energy status can influence lipid signaling pathways in neurons.
fatty acid primary amide biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FAAH | Neuroinflammation, pain, skin inflammation | FAAH knockout or point-mutation cell lines; microglial activation assays |
| MAS1 | Acetaminophen-induced hepatotoxicity | Hepatocyte-specific Mas overexpression or knockout in mouse liver |
| TRPV1 | Pain and nociception | TRPV1 knockout sensory neurons; calcium imaging |
| CNR1/CNR2 | Neuromodulation and inflammation | Cannabinoid receptor knockout or overexpression cell models |
| Lipid metabolism genes (e.g., CPT1A, ACOX1) | Fatty acid oxidation and liver injury | CRISPR knockout hepatocyte lines; lipophagy flux assays |
Fatty acid primary amides in pain and analgesia
Fatty acid primary amides and related lipid signals are implicated in pain processing. Acetaminophen (paracetamol) is proposed to act through mechanisms that include fatty acid amide signaling and TRPV1/cannabinoid-related pathways, which may explain part of its analgesic effect. Mitochondrial activity tunes nociceptor resilience to excitotoxicity, linking neuronal energy metabolism to pain signaling. Because FAAH degrades fatty acid amides, inhibiting FAAH can raise their levels and modulate nociceptive signaling. These observations make GO:0062112 relevant to the development of analgesic strategies that target lipid signaling rather than classical opioid or COX pathways.
Neuroinflammation and microglial activation
Fatty acid amide signaling influences neuroinflammatory responses. Inhibition of fatty acid amide hydrolase protects UVB-activated microglia, indicating that increasing fatty acid amide levels can dampen inflammatory activation in the nervous system. Endocannabinoid hydrolases such as FAAH regulate the availability of lipid mediators that act on cannabinoid receptors, which are expressed in microglia and other immune cells. This places GO:0062112, the biosynthetic arm of fatty acid amide metabolism, in the broader context of neuroinflammation and immune regulation.
Skin barrier function and atopic dermatitis
Stratum corneum lipids are essential for skin barrier function, and their composition is altered in atopic dermatitis. Fatty acid derivatives, including primary amides, contribute to the lipid matrix that controls water loss and protects against environmental insults. Because FAAH inhibition protects UVB-activated microglia, fatty acid amide metabolism may also influence skin inflammation after ultraviolet exposure. Together, these findings connect GO:0062112 to dermatological biology and barrier dysfunction.
Drug-induced hepatotoxicity and liver metabolism
Acetaminophen overdose is a major cause of drug-induced liver injury, and fatty acid handling pathways modulate this toxicity. Hepatocyte-specific Mas activation enhances lipophagy and fatty acid oxidation and protects against acetaminophen-induced hepatotoxicity in mice. Acetaminophen's mechanisms of action have also been linked to fatty acid amide signaling. These studies suggest that GO:0062112 and related lipid metabolic processes are relevant to liver injury and to the development of hepatoprotective strategies.
From fatty acid primary amide biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for fatty acid primary amide production? | CRISPR knockout cell line with lipidomics readout |
| Does a specific point mutation alter enzyme activity? | Point-mutation knock-in cell line |
| Can a tagged enzyme be used to track localization? | Tagged knock-in (e.g., GFP or HA) |
| Does overexpression increase fatty acid amide levels? | Overexpression cell line with targeted lipidomics |
| Does FAAH inhibition change inflammatory responses? | FAAH knockout or inhibitor-treated microglia |
| Does Mas activation protect hepatocytes from acetaminophen? | Hepatocyte-specific Mas overexpression or knockout |
How to Study the fatty acid primary amide biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS/MS lipidomics | Levels of fatty acid primary amides such as oleamide | Quantifying pathway output in cells and tissues |
| Enzymatic activity assay | Fatty acid amide synthase activity | Validating candidate enzymes |
| CRISPR knockout screen | Genes required for fatty acid amide production | Discovery of new pathway components |
| RNA sequencing | Transcriptional changes in lipid and inflammatory genes | Context-dependent regulation |
| Proteomics | Protein abundance and modifications | Identifying pathway enzymes and regulators |
| Immunofluorescence imaging | Subcellular localization of enzymes | Determining endoplasmic reticulum association |
| FAAH activity assay | Hydrolysis of fatty acid amides | Measuring the degradative arm of the pathway |
| Microglial activation assays | Inflammatory cytokine release after UVB | Testing FAAH inhibition in neuroinflammation |
Lipidomics and targeted mass spectrometry
Targeted lipidomics using liquid chromatography-tandem mass spectrometry (LC-MS/MS) is the primary method to measure fatty acid primary amides such as oleamide. This approach can quantify pathway products in cells and tissues and is essential for validating CRISPR models of GO:0062112. Stable isotope-labeled standards improve quantification and allow researchers to distinguish newly synthesized amides from background pools.
Enzymatic activity assays
In vitro enzyme assays using acyl-CoA substrates and ammonia donors can measure fatty acid amide synthase activity directly. These assays help determine whether a candidate gene encodes an enzyme with the expected catalytic activity and are useful for comparing wild-type and mutant proteins generated by CRISPR. Coupling activity assays with lipidomics provides orthogonal validation of pathway function.
CRISPR-based genetic screens
Genome-wide CRISPR knockout or activation screens coupled to lipidomic or reporter readouts can identify genes required for fatty acid primary amide biosynthesis. Such screens are powerful for discovering uncharacterized enzymes in the pathway. Hits can then be validated individually using targeted knockout cell lines and LC-MS/MS.
Transcriptomics and proteomics
RNA sequencing and quantitative proteomics can reveal how expression of candidate genes changes under conditions that alter fatty acid amide levels, such as inflammation or drug treatment. These methods help place GO:0062112 in the context of broader metabolic and inflammatory networks.
How CRISPR Can Be Used to Study GO:0062112 fatty acid primary amide biosynthetic process
Knockout
CRISPR knockout of candidate genes is used to test whether a specific enzyme is required for fatty acid primary amide biosynthesis. For example, knocking out a putative fatty acid amide synthase should reduce oleamide levels, as measured by LC-MS/MS. Knockout of FAAH, by contrast, is expected to increase fatty acid amide levels and can be used to study the degradative arm of the pathway. Knockout models are also useful for testing whether a gene is required for inflammatory responses to UVB in microglia.
Point Mutation
CRISPR point mutation can introduce catalytic-dead or patient-derived mutations into candidate enzymes to separate enzymatic activity from scaffolding functions. This is particularly useful when a gene has multiple domains or when a disease-associated variant is suspected to affect fatty acid amide synthesis. Point-mutant cell lines can be compared with wild-type cells in lipidomic and activity assays to define structure-function relationships.
Knock-in
Knock-in of epitope or fluorescent tags allows researchers to track the localization and interactions of fatty acid amide biosynthetic enzymes in living cells. Tagged knock-in lines can be used for co-immunoprecipitation, proximity labeling, and imaging studies to identify binding partners and membrane domains. Knock-in of reporter cassettes can also provide a readout of pathway activity.
Overexpression
Overexpression of candidate genes can test whether increasing enzyme levels is sufficient to raise fatty acid primary amide production. This approach is useful for gain-of-function studies and for producing sufficient material for biochemical purification. Overexpression models can also be combined with FAAH inhibition to maximize fatty acid amide accumulation and to study downstream signaling.
How EDITGENE Supports fatty acid primary amide biosynthetic process Research
Researchers studying fatty acid primary amide biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in producing fatty acid amides, whether a specific mutation alters enzyme activity, or whether overexpression is sufficient to change pathway output. Answering these questions requires precise genetic models that can be compared with wild-type cells using lipidomic and functional readouts. EDITGENE provides the CRISPR tools and cell models needed to build such experiments efficiently.
Contact EDITGENE today to design your custom CRISPR model for fatty acid primary amide biosynthetic process research.
Frequently Asked Questions About fatty acid primary amide biosynthetic process
What is GO:0062112?
GO:0062112 is the Gene Ontology term for fatty acid primary amide biosynthetic process, the set of reactions that produce fatty acid primary amides such as oleamide.
What is fatty acid primary amide biosynthetic process?
It is the biological process that builds fatty acid primary amides by forming an amide bond from a fatty acid precursor, typically through an acyl-CoA intermediate.
What genes are involved in fatty acid primary amide biosynthetic process?
The best-studied enzyme is the oleamide synthase activity, while FAAH degrades the products; other genes include TRPV1, cannabinoid receptors, and Mas receptor in related signaling.
What is oleamide and how is it made?
Oleamide is the primary amide of oleic acid, produced from oleoyl-CoA by a fatty acid amide synthase activity in the endoplasmic reticulum.
How is fatty acid primary amide biosynthesis regulated?
It is regulated by substrate availability, by the degradative enzyme FAAH, and by metabolic and inflammatory signals such as Mas activation and UVB exposure.
What diseases are linked to fatty acid primary amides?
They are linked to pain, neuroinflammation, skin barrier dysfunction, and drug-induced hepatotoxicity through pathways involving FAAH, TRPV1, cannabinoid receptors, and Mas.
How can I study GO:0062112 in the lab?
Use LC-MS/MS lipidomics to measure fatty acid amides, enzymatic activity assays to test candidate enzymes, and CRISPR knockout or overexpression models to establish causality.
What is the role of FAAH in this pathway?
FAAH hydrolyzes fatty acid amides and opposes the biosynthetic process, so inhibiting FAAH increases fatty acid amide levels and can reduce inflammation.
Does acetaminophen affect fatty acid amide signaling?
Acetaminophen mechanisms of action have been proposed to involve fatty acid amide pathways, including TRPV1 and cannabinoid-related signaling.
What CRISPR models are available for this pathway?
Knockout, point-mutation, knock-in, tagged knock-in, and overexpression models can be generated for candidate genes, and CRISPR screens can identify new pathway components.
Conclusion
GO:0062112, fatty acid primary amide biosynthetic process, defines the production of lipid signaling molecules such as oleamide and related primary amides. The pathway is enzymatically controlled, balanced by FAAH-mediated hydrolysis, and connected to pain, neuroinflammation, skin barrier function, and drug-induced liver injury. Despite its importance, the enzymes that catalyze amide bond formation in mammalian cells remain incompletely characterized, making this an active area for discovery. CRISPR-based knockout, point-mutation, knock-in, and overexpression models combined with lipidomics provide a rigorous path to identify and validate the genes that drive this process. Such work will clarify how fatty acid primary amides are made and how their dysregulation contributes to disease.
References
- 1. Anderson BJ. 2008. Paracetamol (Acetaminophen): mechanisms of action.. Paediatr Anaesth 18(10):915-21 PMID: 18811827
- 2. Chen S et al.. 2023. Hepatocyte-specific Mas activation enhances lipophagy and fatty acid oxidation to protect against acetaminophen-induced hepatotoxicity in mice.. J Hepatol 78(3):543-557 PMID: 36368597
- 3. Yuan L et al.. 2025. Mitochondrial activity tunes nociceptor resilience to excitotoxicity.. Cell 188(23):6436-6452.e18 PMID: 40865527
- 4. Ueda N. 2002. Endocannabinoid hydrolases.. Prostaglandins Other Lipid Mediat 68-69:521-34 PMID: 12432941
- 5. van Smeden J et al.. 2016. Stratum Corneum Lipids: Their Role for the Skin Barrier Function in Healthy Subjects and Atopic Dermatitis Patients.. Curr Probl Dermatol 49:8-26 PMID: 26844894
- 6. Mueller GP et al.. 2009. Biosynthesis of oleamide.. Vitam Horm 81:55-78 PMID: 19647108
- 7. Gao D et al.. 2024. Acetate utilization promotes hormone therapy resistance in prostate cancer through neuroendocrine differentiation.. Drug Resist Updat 77:101158 PMID: 39395327
- 8. Carnicelli V et al.. 2024. Protective effects of fatty acid amide hydrolase inhibition in UVB-activated microglia.. Biochim Biophys Acta Mol Cell Biol Lipids 1869(7):159524 PMID: 38857757
